Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
35.98
-0.30 (-0.83%)
At close: Jun 3, 2026, 4:00 PM EDT
35.34
-0.64 (-1.78%)
After-hours: Jun 3, 2026, 7:58 PM EDT
Legend Biotech Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Legend Biotech stock has a consensus rating of "Buy" and an average price target of $56.39. The average 1-year stock price forecast is 56.73% higher than the current stock price, while the lowest is $27 (-24.96%) and the highest is $86 (+139.02%).
Price Target: $56.39 (+56.73%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Legend Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 9 | 9 | 9 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $31 → $49 | Buy | Maintains | $31 → $49 | +36.19% | Jun 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $64 | Buy | Maintains | $64 | +77.88% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +108.45% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 → $65 | Buy | Reiterates | $50 → $65 | +80.66% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +33.41% | May 13, 2026 |
Financial Forecast
Revenue This Year
1.44B
from 1.03B
Increased by 40.25%
Revenue Next Year
1.82B
from 1.44B
Increased by 26.36%
EPS This Year
0.28
from -1.62
EPS Next Year
1.24
from 0.28
Increased by 344.05%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.4B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 50.8% | ||
| Avg | 40.2% | ||
| Low | 33.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.28 | ||
| Avg | 0.28 | ||
| Low | 0.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.